NL-OMON37397
Completed
Not Applicable
A pharmacokinetic study to compare the bioavailability between MK-0663 (etoricoxib ) 120 mg Tablets from Two Different Manufacturing Sites (Frosst Iberica, Spain versus Elkton, VA, USA). - MK-0663 (CS0177)
Merck Sharp & Dohme (MSD)0 sites24 target enrollmentStarted: TBDLast updated:
Overview
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Merck Sharp & Dohme (MSD)
- Enrollment
- 24
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 99 (—)
Inclusion Criteria
- •Male and female, between 18\-55 years of age, BMI 18\-30\.
Exclusion Criteria
- •Clinical significant abnormalities at medical research
Investigators
Similar Trials
Completed
Not Applicable
Evaluation of Pharmacokinetics, Relative Bioavailability, and Safety of PA-101 in Healthy Subjects, Patients with Systemic Mastocytosis, and Patients with Allergic AsthmaBlood and Lymphatic System DisordersSystemic MastocytosisMastocytosis and Asthma1000170810006436NL-OMON41045Patara Pharma, LLC24
Completed
Not Applicable
Evaluation of Pharmacokinetics, Relative Bioavailability, and Tolerability of Three Different Formulations of PA101 in Healthy Subjects, Patients with Systemic Mastocytosis, and Patients with Chronic Cough due to Idiopathic Pulmonary Fibrosisaandoeningen gerelateerd aan de mast cellen (mastocyten)Systemic Mastocytosis and inflammatory10001708NL-OMON42687PATARA PHARMA, LLC24
Completed
Phase 1
Pharmacokinetic and Pharmacodynamic (PK and PD) Study of Fluticasone Propionate and Salmeterol Combination Product Delivered in a Capsule-based Inhaler and in a Multi-dose Dry Powder Inhaler in Moderate Asthma Patients and Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) Patients.AsthmaNCT01494610GlaxoSmithKline60
Completed
Not Applicable
Pharmacokinetic study to assess the bioavailability of phenolics from an olive leaf extractcardiovascular diseaseosteoporosis100822061000595910047079NL-OMON37716Bio-Actor31
Completed
Not Applicable
Pharmacokinetic study to assess the bioavailability of the cocoa flavanols catechin and epicatechin from different matrices.cardiovascular disease1008220610047079NL-OMON35796Callebaut NV10